References
- Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11:9 - 22; http://dx.doi.org/10.1038/nrc2982; PMID: 21160525
- Kostareli E, Holzinger D, Hess J. New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas. Front Oncol 2012; 2:36; http://dx.doi.org/10.3389/fonc.2012.00036; PMID: 22655271
- Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004; 68:362 - 72; http://dx.doi.org/10.1128/MMBR.68.2.362-372.2004; PMID: 15187189
- Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 2008; 14:366 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-07-1402; PMID: 18223210
- Sirianni N, Wang J, Ferris RL. Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity. Oral Oncol 2005; 41:423 - 8; http://dx.doi.org/10.1016/j.oraloncology.2004.11.003; PMID: 15792615
- Rampias T, Sasaki C, Weinberger P, Psyrri A. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 2009; 101:412 - 23; http://dx.doi.org/10.1093/jnci/djp017; PMID: 19276448
- Li C, Johnson DE. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest. Cell Cycle 2013; 12; In press PMID: 23421999
- Kubicek GJ, Axelrod RS, Machtay M, Ahn PH, Anne PR, Fogh S, et al. Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies. Int J Radiat Oncol Biol Phys 2012; 83:1192 - 7; http://dx.doi.org/10.1016/j.ijrobp.2011.09.023; PMID: 22245208